Stay updated on Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision 3.3.4 was added and Revision 3.3.3 was removed. This change affects only the revision history and does not alter core study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-01-15T10:50:44.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Added an extensive list of Locations across multiple countries and regions. This expands where patients can participate in the trial.
    Difference
    3%
    Check dated 2025-12-17T20:26:42.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The Publications section text was slightly revised and the page revision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-26T08:29:19.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The government funding status notice was removed from the page, which previously warned that information may be out of date due to funding lapses. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-19T08:44:08.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    No significant changes detected on the Study Details page for NCT03829319; the content appears unchanged between the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-28T05:29:51.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    - Updated region name from Rhone-Alpes to Auvergne-Rhône-Alpes and added corresponding address. - Bumped revision from v3.1.0 to v3.2.0. - Added a status notice about government funding and NIH Clinical Center operations.
    Difference
    3%
    Check dated 2025-10-06T16:10:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.